Allied Market Research
Loading...
0
Allied Market Research

Vasomotor Symptoms Market by Therapy Type (Estrogen, Progesterone, Combination, OTC hormone, Anti-depressants, and Others), End User (Hospitals & Clinics, Specialty Centers, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Drug Stores): Global Opportunity Analysis and Industry Forecast, 2021–2030

A12363
Pages: NA
Sep 2021 | 44 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Vasomotor Symptoms Market

Request Now !

Vasomotor symptoms are the most commonly reported symptoms of menopause. Vasomotor symptoms are usually described as hot flashes, night sweats, and flushes. In addition, these symptoms are characterized by a sudden increase in blood flow to the neck, face, and chest, which causes profuse sweating. These symptoms can even cause a disturbed sleep pattern when they occur at night. In totality, vasomotor symptoms vary greatly in their frequency and intensity among menopausal women and are most debilitating in the first two years of menopause. However, for some women, the symptoms can be persistent indefinitely.

Market Scope and Structure Analysis

Report Metric

Details

 Market Size Available for Years

 2020–2030

 Base Year Considered

 2020

 Forecast Period

 2021-2030

 Forecast Unit

 Value (USD)

 Segments Covered

 Therapy Type, End User, Distribution Channel, and Region

 Regions Covered

 North America, Europe, Asia-Pacific, and LAMEA

 Companies Covered

Eli Lily and Company, Emcure Pharmaceuticals Ltd., Merck & Co., Inc., Mithra Pharmaceuticals, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals, TherapeuticsMD, Inc., Procter & Gamble, EndoCeutics, Inc., and Amag Pharmaceuticals

 

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in December, 2019. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since its outbreak, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.

However, with COVID-19, the supply chain of the raw materials required to manufacture therapeutic hormones for vasomotor symptoms has been disrupted in many countries. In addition, the market growth of pharmaceuticals is also declining as the manufacturers of drugs have slowed down their production because of the pandemic. This, in turn, is expected to have a significant impact on the vasomotor symptoms market.

Top Impacting Factors

There is a rise in the number of organizations investing in R&D and clinical trial candidates. This is acting as a major factor for the growth of the vasomotor symptoms market.

Increase in product launches by prominent players in the vasomotor symptoms market is expected to boost the market growth. For instance, in 2019, Otsuka Pharmaceutical launched EQUELLE. EQUELLE is a non-hormonal and non-prescription supplement that helps alleviate the frequency of muscle aches and hot flashes associated with menopause in the U.S.

In developing countries, the awareness regarding menopause and vasomotor symptoms has increased. With rise in awareness, people are open to seek better and advanced treatment options for their conditions.

However, the complications and side-effects associated with treatment options for vasomotor symptoms can reduce the growth of the vasomotor symptoms market. For instance, hormone replacement therapy can cause side effects such as bloating, bleeding, headaches, breast enlargement or tenderness, nausea, and mood changes in women.

Key Market Trends

In 2020, KaNDy Therapeutics received positive data from its ‘SWITCH-1’ clinical trial with its non-hormonal drug candidate NT-814. It helps treat vasomotor symptoms of menopause. Similarly, Radius Pharma has its drug Elacestrant (RAD1901) which can potentially be used in hormone-resistant or hormone-driven breast cancer, and menopause-related vasomotor symptoms in postmenopausal women.

North America holds a major market share of vasomotor symptoms owing to the presence of major players such as Eli Lilly Company and TherapeuticsMD, Inc. These companies have established their clientele in Latin American as well as North American countries.

The European region also holds a significant share of the vasomotor symptoms market. This can be attributed to the increase in various clinical trial studies in European countries. For instance, in 2020, Mithra Pharmaceuticals updated its E4 Comfort clinical program which aimed at enrolling 2200 menopausal women.

Asia-Pacific is predicted to be the fasted growing region in the vasomotor symptoms market. Prominent players are employing many strategic activities like mergers and acquisitions. For instance, in 2017, Mithra Pharmaceuticals signed a license and agreement with Fuji Pharma to commercialize Donesta in Japan.

Key Segments Covered

Segment

Subsegments

 Therapy Type

  • Estrogen
  • Progesterone
  • Combination
  • OTC hormone
  • Anti-Depressants
  • Others

 End User

  • Hospitals & Clinics
  • Specialty Centers
  • Others

 Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Drug Stores

 Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of the Report

  • This study presents the analytical depiction of the vasomotor symptomsindustry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the vasomotor symptomsmarket share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the growth scenario of the vasomotor symptoms market.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Vasomotor Symptoms Report

  • Which are the leading players active in the vasomotor symptoms market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the vasomotor symptoms market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps in the market?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Vasomotor Symptoms Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers